Skip to main content
Novartis
language-selector-globe
Choose Location
  • International
  • Americas
  • Asia Pacific
  • Europe
  • Middle East & Africa
Global | English(link is external)
Novartis Foundation | English(link is external)
Argentina | Español(link is external)
Brazil | Português(link is external)
Canada | English(link is external)
Canada | Français(link is external)
Central America | Español(link is external)
Colombia | Español(link is external)
Mexico | Español(link is external)
United States | English(link is external)
Australia | English(link is external)
Bangladesh | English(link is external)
Hong Kong S.A.R. | 繁體中文(link is external)
India | English(link is external)
Indonesia | English(link is external)
Japan | 日本語(link is external)
Korea | 한국어(link is external)
Mainland China | 中文(link is external)
Malaysia | English(link is external)
Pakistan | English(link is external)
Philippines | English(link is external)
Singapore | English(link is external)
Taiwan | 繁體中文(link is external)
Thailand | ภาษาไทย(link is external)
Austria | Deutsch(link is external)
Belgium | Français(link is external)
Belgium | Nederlands(link is external)
Bulgaria | Български(link is external)
Czech Republic | Česky(link is external)
Czech Republic | English(link is external)
Denmark | Dansk(link is external)
Estonia | Eesti(link is external)
Finland | Suomalainen(link is external)
France | Français(link is external)
Germany | Deutsch(link is external)
Greece | Ελληνικά(link is external)
Hungary | Magyar(link is external)
Ireland | English(link is external)
Italy | Italiano(link is external)
Latvia | Latvian(link is external)
Lithuania | Lithuanian(link is external)
Netherlands | Nederlands(link is external)
Norway | Norsk(link is external)
Poland | Polski(link is external)
Portugal | Português(link is external)
Romania | Română(link is external)
Russia | Русский(link is external)
Serbia | Srpski(link is external)
Slovakia | Slovensky(link is external)
Slovenia | Slovenščina(link is external)
Slovenia | English(link is external)
Spain | Español(link is external)
Sweden | Svenska(link is external)
Switzerland | Deutsch(link is external)
Switzerland | Français(link is external)
Türkiye | Türkçe(link is external)
United Kingdom | English(link is external)
Egypt | English(link is external)
Israel | עברית(link is external)
Saudi Arabia | العربية(link is external)
South Africa | English(link is external)
language-selector-globe
Choose Location
International Americas Asia Pacific Europe Middle East & Africa
Argentina | Español(link is external)
Australia | English(link is external)
Austria | Deutsch(link is external)
Bangladesh | English(link is external)
Belgium | Français(link is external)
Belgium | Nederlands(link is external)
Brazil | Português(link is external)
Bulgaria | Български(link is external)
Canada | English(link is external)
Canada | Français(link is external)
Central America | Español(link is external)
Colombia | Español(link is external)
Czech Republic | Česky(link is external)
Czech Republic | English(link is external)
Denmark | Dansk(link is external)
Egypt | English(link is external)
Estonia | Eesti(link is external)
Finland | Suomalainen(link is external)
France | Français(link is external)
Germany | Deutsch(link is external)
Greece | Ελληνικά(link is external)
Hong Kong S.A.R. | 繁體中文(link is external)
Hungary | Magyar(link is external)
India | English(link is external)
Indonesia | English(link is external)
Ireland | English(link is external)
Israel | עברית(link is external)
Italy | Italiano(link is external)
Japan | 日本語(link is external)
Korea | 한국어(link is external)
Latvia | Latvian(link is external)
Lithuania | Lithuanian(link is external)
Mainland China | 中文(link is external)
Malaysia | English(link is external)
Mexico | Español(link is external)
Netherlands | Nederlands(link is external)
Norway | Norsk(link is external)
Global | English(link is external)
Novartis Foundation | English(link is external)
Pakistan | English(link is external)
Philippines | English(link is external)
Poland | Polski(link is external)
Portugal | Português(link is external)
Romania | Română(link is external)
Russia | Русский(link is external)
Saudi Arabia | العربية(link is external)
Serbia | Srpski(link is external)
Singapore | English(link is external)
Slovakia | Slovensky(link is external)
Slovenia | Slovenščina(link is external)
Slovenia | English(link is external)
South Africa | English(link is external)
Spain | Español(link is external)
Sweden | Svenska(link is external)
Switzerland | Deutsch(link is external)
Switzerland | Français(link is external)
Taiwan | 繁體中文(link is external)
Thailand | ภาษาไทย(link is external)
Türkiye | Türkçe(link is external)
United Kingdom | English(link is external)
United States | English(link is external)
    • About 

      • Board of Directors 

        • Giovanni Caforio 
        • Simon Moroney 
        • Ton Buechner 
        • Patrice Bula 
        • Elizabeth (Liz) Doherty 
        • Ana de Pro Gonzalo 
        • Bridgette Heller 
        • Daniel Hochstrasser 
        • Frans van Houten 
        • Elizabeth McNally 
        • John D. Young 
        • Charlotte Pamer-Wieser 
      • Executive Committee 

        • Vasant (Vas) Narasimhan 
        • Shreeram Aradhye 
        • Victor Bulto 
        • Aharon (Ronny) Gal 
        • Karen L. Hale 
        • Patrick Horber 
        • Harry Kirsch 
        • Rob Kowalski 
        • Steffen Lang 
        • Fiona Marshall 
        • Lutz Hegemann 
        • Kees Roks 
        • Michelle Weese 
      • Products 
      • Therapeutic areas 

        • Cardiovascular, renal and metabolic 
        • Immunology 
        • Neuroscience 
        • Oncology 
      • People and culture 
      • Inclusion 

        • Promoting inclusion 
        • Building belonging 
        • Parental leave 
      • Novartis Gene Therapies 
      • Manufacturing 
      • Quality 

        • Audit program 
        • Novartis quality management system (QMS) 
        • Product and patient safety training 
        • Regulatory inspections 
        • Product recalls 
        • Third-party suppliers 
      • Novartis and the European Union (EU) 
      • Awards and recognition 
      Mother and daughter cuddling on a bed in a kids room

      About

      Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.

    • Patients and caregivers 

      • Novartis commitment to patients and caregivers 
      • Diseases 
      • Patient organization funding 
      • Patients perspectives stories 
      Adult daughter talking to her senior parents on a bench in a park

      Patients and caregivers

      Information for patients and their caregivers including clinical trial recruiting, managed access programs, funding opportunities for patient organizations and side effects reporting.

    • Healthcare professionals 

      • Medical congresses and events 

        • ASCO Annual Meeting 
      • Products 
      • Novartis pipeline 
      • Managed access programs 

        • Zolgensma® Global Managed Access Program (gMAP) 
      • Novartis external funding 
      • Healthcare professional resources by country 
      • Investigator-initiated trials / studies 
      • Novartis medical information 

        • Submit medical enquiry 
      Doctor discussing illness with patient in an office

      Healthcare professionals

      Resources for physicians and other healthcare professionals including clinical trial recruiting, grant funding, congresses and country-level information.

    • Research and development 

      • Technology platforms 
      • Research disease areas 

        • Cardiovascular and metabolic disease research at Novartis 
        • DAx: exploratory disease research at Novartis 
        • Global Health disease area research at Novartis 
        • Immunology disease research at Novartis 
        • Neuroscience research at Novartis 
        • Oncology research at Novartis 
      • Novartis pipeline 
      • Research collaborations 
      • Collaborations 
      A female research scientist in a lab looking at a sample

      Research & development

      Discover how Novartis turns breakthrough science into transformative, high-value treatments.
       

    • ESG 

      • Access 

        • Creating sustainable business models 
        • Value-based pricing 
        • Sub-Saharan Africa 
        • Donations 
        • Novartis access principles 
        • Novartis oncology access 
        • Patents and licensing 
      • Environmental sustainability 

        • Climate 
        • Nature - Waste 
        • Nature - Water 
      • Ethics, risk and compliance 

        • Ethical behavior 
        • Compliance 
        • Human rights 
        • Learning and engagement 
        • Integrated risk assurance 
      • Global health 

        • Pandemic preparedness 
        • Avoidable blindness 
        • Chagas disease 
        • Leprosy 
        • Malaria 
        • Sickle cell disease (SCD) 
        • Novartis Foundation  (link is external)
      • Inclusion 
      • ESG index 
      • Reporting and transparency hub 

        • ESG rating performance 
        • Targets 
        • Patient organization funding 
        • Payments to healthcare professionals 
        • Public policy 
        • A living wage 
        • A safe workplace 
        • Animal research 
      Family and friends having a party at home

      Environmental, social and governance

      Learn about our commitments to making a positive impact on the world by providing access to innovative medicines, protecting the environment, and upholding high ethical standards. Explore the Novartis in Society Integrated Report.

    • Investors 

      • Event calendar 
      • Financial data 

        • Novartis annual results 
        • Novartis quarterly results 
        • Novartis SEC filings 
        • Product sales 
        • Fixed-income securities 
        • Expected currency impact 
      • Share data and analysis 

        • Share monitor 
        • Dividend information 
        • Share ownership 
        • Share overview 
        • Return on investment calculator 
      • Shareholder information 

        • General Meetings 
        • American Depositary Receipts (ADR) 
        • Share buyback 
        • Frequently asked questions 
      • Company overview 

        • Corporate governance 
      • Reporting and transparency hub 

        • Reporting archive 
        • ESG rating performance 
        • Publications order form 
      • ESG 
      Business woman working on her laptop in a bright atmosphere

      Investors

      Updates and resources for investors including financial information, disclosures, events, share price, ESG and reporting.

    • News 

      • News archive  
      • Media library  
      • Stories 
      • Subscribe 
      • Events 
      Overhead view of a meeting room with people in the foreground and screens in the background

      News

      Information for journalists including media releases, statements, stories, multimedia resources and more.

    • Careers 

      • Career search 
      • Our business functions 

        • Careers in research and development 
        • Careers in operations 
        • Careers in commercial and sales 
        • Careers in global functions 
      • Why Novartis 
      • Career hub 

        • Temporary contracts  (link is external)
      • Early careers 

        • Graduates 
        • Students 
        • US Biomedical Research internship programs 
        • Community exploration and learning lab (CELL) 
      Two business people

      Careers

      Novartis is hiring! Find open positions, learn more about our strategy and culture, and apply today.

    • Clinical trials 
    • Partnering 
    • Supplier portal 
    • Report side effects 
    • Contacts 
    Grandmother, mother and daughter smiling and laughing on a beach

    Home

    Working together, we can reimagine medicine to improve and extend people’s lives.

  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title Sort ascending
  • Site
  • Location
  • Division
  • Business
  • Functional Area
  • Date Posted
Job Title Sort ascending Site Location Division Business Functional Area Date Posted
Praktikant Medical ab 112025 Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Germany International Universal Hierarchy Node Others May 08, 2025
Post Doc RNA Delivery Basel (City) Switzerland Development Innovative Medicines Others May 08, 2025
Internship Pharmaceutical Development (Solid Oral Dosage Forms) 12-18 Months Basel (City) Switzerland Development Innovative Medicines Others May 08, 2025
MR Intern Changsha (Hunan Province) China International Innovative Medicines Others May 08, 2025
Postgraduate GCS Ops Clinical Packaging Basel (City) Switzerland Development Innovative Medicines Others May 07, 2025
Quality Control Trainee Guido Caloi Brazil Operations Innovative Medicines Others May 07, 2025
Aprendiz Sena Oncología Bogota (Pharmaceuticals / GDD / NTO / CTS) Colombia International Innovative Medicines Others May 06, 2025
Aprendiz Sena Oncología Bogota (Pharmaceuticals / GDD / NTO / CTS) Colombia International Innovative Medicines Others May 06, 2025
Aprendiz Sena Oncología Bogota (Pharmaceuticals / GDD / NTO / CTS) Colombia International Innovative Medicines Others May 06, 2025
Aprendiz Sena Oncología Bogota (Pharmaceuticals / GDD / NTO / CTS) Colombia International Innovative Medicines Others May 06, 2025
Aprendiz Sena Oncología Bogota (Pharmaceuticals / GDD / NTO / CTS) Colombia International Innovative Medicines Others May 06, 2025
Aprendiz Sena Oncología Bogota (Pharmaceuticals / GDD / NTO / CTS) Colombia International Innovative Medicines Others May 06, 2025
Aprendiz Sena Oncología Bogota (Pharmaceuticals / GDD / NTO / CTS) Colombia International Innovative Medicines Others May 06, 2025
Aprendiz Sena Oncología Bogota (Pharmaceuticals / GDD / NTO / CTS) Colombia International Innovative Medicines Others May 06, 2025
Aprendiz Sena Oncología Bogota (Pharmaceuticals / GDD / NTO / CTS) Colombia International Innovative Medicines Others May 06, 2025
Aprendiz Sena Oncología Bogota (Pharmaceuticals / GDD / NTO / CTS) Colombia International Innovative Medicines Others May 06, 2025
MR Intern Nanjing (Jiangsu Province) China International Innovative Medicines Others May 06, 2025
Aprendiz Sena Oncología Bogota (Pharmaceuticals / GDD / NTO / CTS) Colombia International Innovative Medicines Others May 06, 2025
Lehrling Elektrotechnik Schaftenau Austria Operations Innovative Medicines Others May 05, 2025
Lehrling Mechatronik Schaftenau Austria Operations Innovative Medicines Others May 05, 2025
Lehre Labortechnik Schaftenau Austria Operations Innovative Medicines Others May 05, 2025
Lehrling Chemieverfahrenstechnik Schaftenau Austria Operations Innovative Medicines Others May 05, 2025
MR Intern Guangzhou (Guangdong Province) China International Innovative Medicines Others May 05, 2025
Medical Lead Neurosciences (H/F) en stage Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Others Apr 30, 2025
MR Intern Zhengzhou (Henan Province) China International Innovative Medicines Others Apr 30, 2025
Postdoc Drug Product Development Data/Computational Scientist Oligonucleotide Platform Basel (City) Switzerland Development Innovative Medicines Others Apr 30, 2025
MEDICAL LEAD (H/F) en alternance Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Others Apr 30, 2025
MR Intern Changchun (Jilin Province) China International Innovative Medicines Others Apr 30, 2025
Expert dveloppement des compétences (H/F) en alternance Paris Headquarter (Novartis Pharma S.A.S.) France Pharma Innovative Medicines Others Apr 29, 2025
MR Intern Guangzhou (Guangdong Province) China International Innovative Medicines Others Apr 29, 2025
MR Intern Hangzhou (Zhejiang Province) China International Innovative Medicines Others Apr 28, 2025
MR Intern Tianjin (Tianjin) China International Innovative Medicines Others Apr 26, 2025
Chef de Projet Omnicanal (H/F) en alternance Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Others Apr 25, 2025
Solutions digitales & développement d'automatisations (H/F) en alternance Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Others Apr 25, 2025
MR Intern Quanzhou (Fujian Province) China International Universal Hierarchy Node Others Apr 25, 2025
MR Intern Nanjing (Jiangsu Province) China International Innovative Medicines Others Apr 23, 2025
Chef de produit hématologie (H/F) en alternance Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Others Apr 23, 2025
Master Student in Translational M&S Basel (City) Switzerland Biomedical Research Pharma Research Others Apr 23, 2025
MR intern Guangzhou (Guangdong Province) China International Innovative Medicines Others Apr 23, 2025
MR Intern Xi an (Shaanxi Province) China International Innovative Medicines Others Apr 23, 2025
MR Intern Fuzhou (Fujian Province) China International Innovative Medicines Others Apr 23, 2025
MR Intern Dalian (Liaoning Province) China International Innovative Medicines Others Apr 22, 2025
MR Intern Suzhou (Jiangsu Province) China International Innovative Medicines Others Apr 21, 2025
MR Intern Xiangtan (Hunan Province) China International Innovative Medicines Others Apr 21, 2025
Legal Intern İstanbul Kavacık Türkiye Legal Innovative Medicines Others Apr 14, 2025
MR Intern Beijing (Beijing) China International Innovative Medicines Others Apr 14, 2025
MR Intern Chengdu (Sichuan Province) China International Innovative Medicines Others Apr 10, 2025
MR Intern Xi an (Shaanxi Province) China International Innovative Medicines Others Apr 10, 2025
MR Intern Shanghai (Shanghai) China International Innovative Medicines Others Apr 10, 2025
MR Intern Xi an (Shaanxi Province) China International Innovative Medicines Others Apr 10, 2025

Pagination

  • ‹ Previous page
  • 1
  • 2
  • › Next page

Novartis

Working together
  • Patients and caregivers
  • Healthcare professionals
  • Researchers
  • Job seekers
  • Journalists
  • Investors
Topics
  • Q1 2025
  • Eurovision
  • Access
  • ESG
  • SpeakUp
Explore
  • Pipeline
  • Products
  • Clinical trials
  • Partnering
  • Events
Therapeutic areas
  • Cardiovascular, renal and metabolic
  • Immunology
  • Neuroscience
  • Oncology
  • (link is external)
  • (link is external)
  • (link is external)
  • (link is external)
  • (link is external)
Footer Bottom
© 2025 Novartis AG
  • Terms of use
  • Privacy
  • Cookie settings
  • Contacts
  • Locations
  • Site map
  • Open source
  • Web accessibility
Novartis Site Directory
This site is intended for a global audience